MEK inhibitor

CAS No. 334951-92-7

MEK inhibitor( —— )

Catalog No. M33014 CAS No. 334951-92-7

MEK inhibitor is a tyrosine kinase receptor and cell cycle protein/CDK complex inhibitor with antitumor activity and can be used to study tumor cell proliferation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 164 Get Quote
5MG 258 Get Quote
10MG 360 Get Quote
25MG 579 Get Quote
50MG 815 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MEK inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    MEK inhibitor is a tyrosine kinase receptor and cell cycle protein/CDK complex inhibitor with antitumor activity and can be used to study tumor cell proliferation.
  • Description
    MEK inhibitor is a potent MEK inhibitor with antitumor potency.
  • In Vitro
    MEK inhibitor is a potent MEK inhibitor. MEK is a kinase enzyme which phosphorylates MAPKs. The activated MAPK leads to the phosphorylation of downstream transcription factors that regulate various responses such as stress signaling, pathogen response, and hormone signaling.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    334951-92-7
  • Formula Weight
    426.51
  • Molecular Formula
    C26H26N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (117.23 mM; Ultrasonic )
  • SMILES
    C(\NC1=CC(CN(C)C)=CC=C1)(=C\2/C=3C(NC2=O)=CC(C(NC)=O)=CC3)/C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MEK inhibitor

    MEK inhibitor is a tyrosine kinase receptor and cell cycle protein/CDK complex inhibitor with antitumor activity and can be used to study tumor cell proliferation.

  • Refametinib

    A potent, non–ATP-competitive, highly selective, allosteric inhibitor of MEK1/2 with IC50 of 19/47 nM respectively.

  • GSK-114

    GSK-114 is a potent, selective TNNI3K inhibitor with IC50 of 25 nM.